Showing 5,741 - 5,760 results of 8,751 for search '1Q84~', query time: 0.93s Refine Results
  1. 5741
  2. 5742
  3. 5743

    Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials by Tyler Pitre, Daniel Lupas, Jasmine Mah, Matthew Stanbrook, Alina Blazer, Dena Zeraatkar, Terence Ho

    Published 2025-01-01
    “…Dupilumab may reduce exacerbations more than tezepelumab (RR 0.82 [95% CI 1.14]) (low certainty). For all patients, no treatment improved FEV1 above the pre-specified minimal clinically important difference (MCID) of 0.1 L. …”
    Get full text
    Article
  4. 5744

    Tobacco cv. Solaris seed cake as feed for light lambs: growth performance, carcase traits and meat quality by Antonella Fatica, Marisa Palazzo, Siria Tavaniello, Meng Peng, Dereje Birara Teshale, Giuseppe Maiorano, Elisabetta Salimei

    Published 2025-12-01
    “…Fatty acid composition showed lower palmitic acid (C16:0, p < 0.05) and higher stearic acid (C18:0, p < 0.01) content in SSC compared to CTR fed lambs. …”
    Get full text
    Article
  5. 5745

    External validation of the prediction model of intradialytic hypotension: a multicenter prospective cohort study by Yuhe Xiang, Guoting Ma, Qin Yang, Min Cao, Wenbin Xu, Lin Li, Qian Yang

    Published 2024-12-01
    “…Decision Curve Analysis (DCA) was employed to evaluate the clinical benefit of updating the model.Results The final cohort comprised 2235 individuals undergoing maintenance hemodialysis, exhibiting a 14.6% occurrence rate of IDH. The externally validated Area Under the Curve (AUC) values for the three original prediction models were 0.746 (95% CI: 0.718 to 0.775), 0.709 (95% CI: 0.679 to 0.739), and 0.735 (95% CI: 0.706 to 0.764) respectively. …”
    Get full text
    Article
  6. 5746
  7. 5747

    Association of frequent intradialytic hypotension with the clinical outcomes of patients on hemodialysis: a prospective cohort study by Yuanhao Wu, Jianda Lu, Tingting Wang, Xiaoye Zhu, Jun Xue, Li You

    Published 2024-12-01
    “…Multivariable Cox regression analysis indicated that frequent IDH was independently associated with a higher risk of all-cause mortality (Model 1: HR = 2.553, 95%CI 1.334–4.886, p = 0.005; Model 2: HR = 2.406, 95%CI 1.253–4.621, p = 0.008). …”
    Get full text
    Article
  8. 5748
  9. 5749
  10. 5750
  11. 5751
  12. 5752
  13. 5753
  14. 5754
  15. 5755

    Shenkang injection for the treatment of acute kidney injury: a systematic review and meta-analysis by Shengchun Liao, Yurou Chen, Shuting Wang, Chen Wang, Chaoyang Ye

    Published 2024-12-01
    “…Secondary outcomes included blood urea nitrogen (BUN), serum cystatin C (CysC), 24-h urine protein (24 h-Upro) levels, APACHE II score and adverse reactions.Results This meta-analysis included eleven studies, and the analysis indicated that, compared with the control group, SKI significantly decreased SCr [WMD = −23.31, 95% CI (-28.06, −18.57); p < 0.001]; BUN [WMD = −2.07, 95% CI (-2.56, −1.57); p < 0.001]; CysC [WMD = −0.55, 95% CI (-0.78, −0.32), p < 0.001]; 24-h urine protein [WMD = −0.43, 95% CI (-0.53, −0.34), p < 0.001]; and the APACHE II score [WMD = −3.07, 95% CI (-3.67, −2.48), p < 0.001]. …”
    Get full text
    Article
  16. 5756

    Changes in serum sodium concentration during hemodialysis is a predictor of mortality and cardio-cerebrovascular event by Qixing Liu, Ke Zheng, Haiyun Wang, Dan Song, Xuemei Li

    Published 2024-12-01
    “…Time-averaged ΔSNa also demonstrated an association with all-cause mortality (3-year ΔSNa: HR [95% CI] 1.26 [1.03–1.55], p = 0.026) as well as with CCVE (3-year ΔSNa: HR [95% CI] 1.51 [1.21–1.88], p = <0.001) when fully adjusted. Baseline pre-HD SNa and ΔSNa didn’t exhibit association with both outcomes.Conclusions Lower time-averaged pre-HD SNa and higher time-averaged ΔSNa were associated with a greater risk of all-cause mortality and CCVE in HD patients.…”
    Get full text
    Article
  17. 5757
  18. 5758
  19. 5759

    High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial by Verena Theiler-Schwetz, Christian Trummer, Lisa Schmitt, Angelika Terbuch, Barbara Obermayer-Pietsch, Erika Richtig, Stefan Pilz

    Published 2025-12-01
    “…The primary outcome was the frequency of hormonal axes recovery.Results Between 17th April 2019 and 16th September 2022, 18 out of the 20 randomised patients finished the trial; eight completed high-dose, 10 glucocorticoid replacement. …”
    Get full text
    Article
  20. 5760